
Episode 31: Polaris Partners' Amy Schulman
Episode 31
She describes her career beginnings as a lawyer, which led to general counsel and business unit head roles at Pfizer, and then joining the VC world at Polaris Partners (at Bob Langer's urging). She discusses the firm's investment philosophy, the nuances behind how companies choose lead assets, and the cycles biotech has been through over the last ten years. Plus, other roles she currently serves, including being the chair of Alnylam.
Publisher
BioVenture VoiCes with Chris Garabedian
Link
podcasters.spotify.com/pod/show/biotechtv7/episodes/Episode-31-Polaris-Partners-Amy-Schulman-e3cu1ih
Published
December 29, 2025
Duration
1h 3m
Format
Podcast
Category
Issues · Science
Source
RSS feed
Host
BiotechTV
BioVenture VoiCes with Chris Garabedian
@bioventurevoiceswithchrisgar
#polarispartnersamy #lifesciences
